SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-014263
Filing Date
2019-04-30
Accepted
2019-04-30 16:02:39
Documents
7
Period of Report
2019-06-10
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A sndx-def14a_20190610.htm DEF 14A 1045524
2 GRAPHIC g525jgrgqrhy000005.jpg GRAPHIC 67939
3 GRAPHIC g525jgrgqrhy000001.jpg GRAPHIC 2898
4 GRAPHIC g525jgrgqrhy000004.jpg GRAPHIC 1659
5 GRAPHIC g525jgrgqrhy000003.jpg GRAPHIC 2915
6 GRAPHIC g525jgrgqrhy000002.jpg GRAPHIC 1377
7 GRAPHIC g525jgrgqrhy000006.jpg GRAPHIC 58347
  Complete submission text file 0001564590-19-014263.txt   1233583
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37708 | Film No.: 19781561
SIC: 2834 Pharmaceutical Preparations